Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

Cell Reports(2022)10.1016/j.celrep.2022.111650Source: DataRank Database

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2 is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (27)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Yiquan Wang ORCID,Huibin Lv ORCID,Timothy J.C. Tan ORCID,Ian A. Wilson ORCID,Nicholas C. Wu ORCID

Live enrichment

PubMed:36335937 PMC:PMC9606039

NIAID NIH HHS

Grant: R01 AI167910

NCCIH NIH HHS

Grant: DP2 AT011966

National Institutes of Health

Grant: 4DP2AT011966-02

High-throughput identification of antibody features for sequence-based epitope prediction

National Institutes of Health

Grant: 5R01AI167910-04

Sequence-function relationship of influenza broadly neutralizing antibodies

Bill and Melinda Gates Foundation

Pasteur Institute

Michelson Prize and Grants

National Institutes of Health

Influential Citations

goldLicense: CC BY

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128778

publisherhttps://api.elsevier.com/content/article/PII:S2211124722015212?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722015212?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC9606039

Europe_PMChttps://europepmc.org/articles/PMC9606039?pdf=render

Fields of Study

MedicineBiology0301 basic medicine03 medical and health sciences

MeSH Terms

HumansReceptors, VirusAntibodies, ViralBroadly Neutralizing AntibodiesCOVID-19SARS-CoV-2COVID-19 Vaccines

Keywords

Sequence analysisdata miningBroadly NeutralizingCovid-19Sars-cov-2Cp: MicrobiologyCp: ImmunologyVariants Of ConcernPublic AntibodyAllelic PreferenceCOVID-19 VaccinesReportHumansReceptors, VirusAntibodies, ViralBroadly Neutralizing Antibodies

Sustainable Development Goals

SDG 3: 3. Good health

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

FAIR Checklist

Authors (6)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)